Analgesia for retinopathy of prematurity screening: A systematic review

Arun J Thirunavukarasu1,2, Refaat Hassan1,3, Shalom V Savant1,4

  • 1School of Clinical Medicine, University of Cambridge, Cambridge, UK.

Insights

Oral paracetamol effectively reduces pain during retinopathy of prematurity (ROP) screening in premature infants. While intranasal fentanyl also helps, its routine use is not advised due to side effects. Further research is needed for optimal pain management.

Area of Science:

  • Neonatal ophthalmology
  • Pain management in neonates
  • Pharmacology

Background:

  • Premature neonates require regular eye exams for retinopathy of prematurity (ROP).
  • Current pain management (topical anesthetics, sugar solution) is insufficient.
  • This review evaluates alternative pharmacological analgesics for ROP screening pain.

Purpose of the Study:

  • To systematically review pharmacological interventions for pain during ROP screening in neonates.
  • To assess the efficacy of various analgesics in reducing pain scores.

Main Methods:

  • Systematic review following PRISMA guidelines (PROSPERO CRD42022302459).
  • Searched electronic databases for studies on pharmacological pain interventions for ROP screening.
  • Analyzed pain scores using validated tools, categorizing interventions into topical anesthesia and alternative treatments.

Main Results:

  • Eleven studies met inclusion criteria.
  • Topical analgesia, oral paracetamol, and intranasal fentanyl effectively reduced pain during eye exams.
  • Oral morphine and inhaled nitrous oxide showed no significant effect on pain scores.

Conclusions:

  • Oral paracetamol is recommended as a premedication for ROP screening.
  • Routine fentanyl use is discouraged due to potential side effects.
  • Non-pharmacological methods should be used; further research is needed for optimal analgesic strategies.
Abstract

Related Concept Videos